Last reviewed · How we verify

EV71 vaccine and influenza vaccine

China National Biotec Group Company Limited · FDA-approved active Biologic

EV71 vaccine and influenza vaccine is a vaccine Biologic drug developed by China National Biotec Group Company Limited. It is currently FDA-approved for Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease, Prevention of seasonal influenza.

This is a combination vaccine that stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71 (EV71) and influenza viruses.

This is a combination vaccine that stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71 (EV71) and influenza viruses. Used for Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease, Prevention of seasonal influenza.

At a glance

Generic nameEV71 vaccine and influenza vaccine
SponsorChina National Biotec Group Company Limited
Drug classvaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

EV71 vaccine contains inactivated enterovirus 71 virus particles that trigger humoral and cell-mediated immune responses to prevent EV71 infection, which causes hand-foot-and-mouth disease. The influenza vaccine component provides protection against seasonal influenza strains through similar immunogenic mechanisms. The combination allows simultaneous protection against both pathogens in a single administration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about EV71 vaccine and influenza vaccine

What is EV71 vaccine and influenza vaccine?

EV71 vaccine and influenza vaccine is a vaccine drug developed by China National Biotec Group Company Limited, indicated for Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease, Prevention of seasonal influenza.

How does EV71 vaccine and influenza vaccine work?

This is a combination vaccine that stimulates the immune system to produce antibodies and cellular immunity against enterovirus 71 (EV71) and influenza viruses.

What is EV71 vaccine and influenza vaccine used for?

EV71 vaccine and influenza vaccine is indicated for Prevention of enterovirus 71 (EV71) infection and hand-foot-and-mouth disease, Prevention of seasonal influenza.

Who makes EV71 vaccine and influenza vaccine?

EV71 vaccine and influenza vaccine is developed and marketed by China National Biotec Group Company Limited (see full China National Biotec Group Company Limited pipeline at /company/china-national-biotec-group-company-limited).

What drug class is EV71 vaccine and influenza vaccine in?

EV71 vaccine and influenza vaccine belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is EV71 vaccine and influenza vaccine in?

EV71 vaccine and influenza vaccine is FDA-approved (marketed).

What are the side effects of EV71 vaccine and influenza vaccine?

Common side effects of EV71 vaccine and influenza vaccine include Injection site pain, redness, or swelling, Fever, Myalgia, Fatigue.

Related